Associated Papers
Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practice.
Maekawa S et al.
Japanese Journal of Clinical Oncology, 2024
Select a paper to view details